Indian injectable products company MSN Labs reported on Thursday the receipt of approval from the US FDA approval to market its generic version of Toremifene 60mg tablets & Aminocaproic Acid 500mg tablet under the label of Novadoz, MSN's US sales affiliate.

The company stated Toremifene 60mg tablets is AB rated to Kyowa Kirin's Fareston & Aminocaproic Acid 500mg tablet is AB rated Clover's Amicar.

Effective immediately, the company has commenced shipping of Toremifene, with Aminocaproic Acid to begin shortly.

According to the company, Toremifene 60mg is an estrogen agonist/antagonist for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor-positive or unknown tumors. The product is supplied in bottles of 60 tablets.

In addition, Aminocaproic Acid 500mg tablets are indicated in the use of enhancing hemostasis when fibrinolysis contributes to bleeding. It is primarily utilized when rapid dissolving of blot clots occurs. The product is supplied in bottles of 30 tablets, concluded the company.